JP2008044932A5 - - Google Patents

Download PDF

Info

Publication number
JP2008044932A5
JP2008044932A5 JP2007187843A JP2007187843A JP2008044932A5 JP 2008044932 A5 JP2008044932 A5 JP 2008044932A5 JP 2007187843 A JP2007187843 A JP 2007187843A JP 2007187843 A JP2007187843 A JP 2007187843A JP 2008044932 A5 JP2008044932 A5 JP 2008044932A5
Authority
JP
Japan
Prior art keywords
methoxy
benzimidazol
thiazolidine
benzyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007187843A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008044932A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2007187843A priority Critical patent/JP2008044932A/ja
Priority claimed from JP2007187843A external-priority patent/JP2008044932A/ja
Publication of JP2008044932A publication Critical patent/JP2008044932A/ja
Publication of JP2008044932A5 publication Critical patent/JP2008044932A5/ja
Pending legal-status Critical Current

Links

JP2007187843A 2006-07-21 2007-07-19 チアゾリジンジオン化合物を含有する組成物 Pending JP2008044932A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007187843A JP2008044932A (ja) 2006-07-21 2007-07-19 チアゾリジンジオン化合物を含有する組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006198953 2006-07-21
JP2007187843A JP2008044932A (ja) 2006-07-21 2007-07-19 チアゾリジンジオン化合物を含有する組成物

Publications (2)

Publication Number Publication Date
JP2008044932A JP2008044932A (ja) 2008-02-28
JP2008044932A5 true JP2008044932A5 (https=) 2010-08-19

Family

ID=39179010

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007187843A Pending JP2008044932A (ja) 2006-07-21 2007-07-19 チアゾリジンジオン化合物を含有する組成物

Country Status (1)

Country Link
JP (1) JP2008044932A (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3788877B1 (en) 2007-04-11 2024-08-07 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ293016B6 (cs) * 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
JP2001039976A (ja) * 1999-05-24 2001-02-13 Sankyo Co Ltd 縮合複素環化合物の塩酸塩
JP2001072671A (ja) * 1999-06-28 2001-03-21 Sankyo Co Ltd ベンズイミダゾール化合物の合成中間体およびその製造方法

Similar Documents

Publication Publication Date Title
IL216928A (en) A crystalline form of 2- {4- [n- (5,6-diphenylpyrazine-2-ram) - n-isopropylamino] butoxy} - n- (methylsulfonyl) acetamide, its pharmaceutical composition and its use in the preparation of a drug
CL2007003609A1 (es) Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion
JP2006519866A5 (https=)
NZ614151A (en) Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
CL2008000134A1 (es) Compuesto 5-[4-(2 metil fenil)-3-hidroxi-4h-[1,2,4] triazol-5-il]-2,4-dihidroxi n metil n butil benzamida; composicion farmaceutica que contiene a dicho compuesto; kit farmaceutico que contiene a dicho compuesto; y su uso para tratar cancer, enfermed
JP2011522816A5 (https=)
PH12012500168A1 (en) Crystalline solvates and complexes of (is)-1,5-anhydro-l-c-(3-((phenyl)methyl)phenyl)-d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes
JP2012500090A5 (https=)
IL200956A0 (en) 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
RU2582676C3 (ru) Некоторые химические соединения, композиции и способы
JP2012502037A5 (https=)
PL2465522T3 (pl) Chemeryna-15h i jej zastosowanie do leczenia zapalenia& xa;i wstrząsu endotoksycznego
NZ599480A (en) Solid forms comprising (-)-o-desmethylvenlafaxine and uses thereof
JP2012533559A5 (https=)
WO2007106022A3 (en) A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof.
JP2008013542A5 (https=)
JP2008044932A5 (https=)
EA201000926A1 (ru) Пиперазины в качестве агентов против ожирения
TNSN08506A1 (en) Substituted carboxamides
IL195441A0 (en) Use of trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine and its formamide in the preparation of medicaments for the treatment of pain disorders
UA108888C2 (xx) Кристал аміду
BRPI0810997A2 (pt) Composto, pró-droga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono em um mamífero, e, uso do composto
MX2007003105A (es) Derivados de bencimidazol, composiciones que los contienen, sus preparaciones y sus usos i.
TW200800993A (en) Organic compounds
JP2008007526A5 (https=)